Orion
Krista Ojala is an experienced professional in pharmaceutical research and development, currently serving as the Head of Biopharmaceutics and Chemical Analytics at Orion Corporation since April 2022. Previously, Krista held the position of Senior Lecturer in the Project Management Program (MBA) at Turku University of Applied Sciences from May 2021 to April 2022. Krista's extensive career at Orion Corporation spans over 24 years, encompassing various roles including Principal Scientist in Biopharmaceutics, Head of Discovery Analytics, and Senior Research Scientist in Analytical Development. Krista began their professional journey at UPM Pulp as a Chemist practicant in 1995 and 1996. Krista holds a Master of Science degree in Organic Chemistry from the University of Jyväskylä, obtained in 1996.
This person is not in the org chart
This person is not in any teams
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.